Program in Immunology,
Department of Pathology and Immunology
Yun Zhang has not added Biography.
If you are Yun Zhang and would like to personalize this page please email our Author Liaison for assistance.
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Oncogene Oct, 2002 | Pubmed ID: 12400010
The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
Cancer research Nov, 2002 | Pubmed ID: 12438218
Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
Journal of the National Cancer Institute Dec, 2003 | Pubmed ID: 14679152
Cigarette suppresses the expression of P4Halpha and vascular collagen production.
Biochemical and biophysical research communications Oct, 2004 | Pubmed ID: 15369792
Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells.
FEBS letters Jan, 2005 | Pubmed ID: 15670837
The AP-1 transcription factor regulates postnatal mammary gland development.
Developmental biology Jul, 2006 | Pubmed ID: 16678816
TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.
Arteriosclerosis, thrombosis, and vascular biology Aug, 2007 | Pubmed ID: 17478756
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2007 | Pubmed ID: 17947490
Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene.
The Journal of biological chemistry May, 2008 | Pubmed ID: 18390539
Protective effects of a compound herbal extract (Tong Xin Luo) on free fatty acid induced endothelial injury: implications of antioxidant system.
BMC complementary and alternative medicine , 2008 | Pubmed ID: 18625049
Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.
Cancer prevention research (Philadelphia, Pa.) Jun, 2008 | Pubmed ID: 19138935
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.
Journal of the National Cancer Institute Jan, 2009 | Pubmed ID: 19141783
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
Cancer prevention research (Philadelphia, Pa.) Feb, 2009 | Pubmed ID: 19174577
Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.
Diabetes Oct, 2009 | Pubmed ID: 19592618
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2014 | Pubmed ID: 25024203
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Breast cancer research and treatment 08, 2016 | Pubmed ID: 27393618
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.
Cell 05, 2019 | Pubmed ID: 31031003
Short ragweed pollen promotes M2 macrophage polarization via TSLP/TSLPR/OX40L signaling in allergic inflammation.
Mucosal immunology 09, 2019 | Pubmed ID: 31350466
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.
NPJ breast cancer , 2019 | Pubmed ID: 31372497
MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis.
European journal of immunology 12, 2019 | Pubmed ID: 31411745
Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
Nature communications 04, 2020 | Pubmed ID: 32273506
IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation.
Mucosal immunology Nov, 2020 | Pubmed ID: 32358573
SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis.
Molecular cancer research : MCR Jul, 2020 | Pubmed ID: 32661114
Daniel E. Morales-Mantilla1,2,
Xinyan Huang3,7,
Philip Erice1,3,
Paul Porter4,
Yun Zhang1,5,
Mary Figueroa6,
Joya Chandra6,
Katherine Y. King2,
Farrah Kheradmand4,8,
Antony Rodríguez3,8
1Program in Immunology, Baylor College of Medicine,
2Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine,
3Department of Medicine - Immunology Allergy and Rheumatology, Baylor College of Medicine,
4Department of Medicine, Pulmonary, Critical Care, Sleep Medicine, Baylor College of Medicine,
5Department of Pathology and Immunology, Baylor College of Medicine,
6Department of Pediatrics, Research and Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center,
7Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University,
8Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center